menu toggle

AmerisourceBergen Fall Gene Therapy Events

Every innovator needs a connector. We exist to connect you. 
You didn’t get the chance to join us at our recent industry conferences? Keep reading to access our insights from the CAR-TCR Summit, Reuters Cell Therapy USA and Meeting on the Mesa.
CAR-TCR cell and gene therapy solutions

Meet with our experts

Groundbreaking gene therapies are paving the path to a healthier tomorrow. And because these life-changing products require equally innovative commercialization partners, AmerisourceBergen is committed to solutions that light the way. Schedule time to meet with our experts at Advanced Therapies Week in Miami, Cell & Gene Therapy Manufacturing & Commercialization Europe 2022 in Amsterdam, or the 6th Annual Cell & Gene Therapy Innovation Leaders Summit.

Gene therapy solutions

AmerisourceBergen

See solutions that enable connections

As healthcare advances, so much the process that connect patients to the therapies they need. Each patient's path to treatment is unique.  And because a rapidly evolving cell therapy market requires an equally innovative partner, AmerisourceBergen is committed to delivering solutions that enable this connection. 

World Courier

Build your advanced therapy supply chain

Managing critical shipments for advanced therapy developers since 2005, through a network of 120+ facilities, a full range of cryogenic shippers and a single quality system, World Courier helps manufacturers build robust logistics platforms that support the clinical development and commercialization of therapies to meet patient treatment needs.

Innomar Strategies

Take the direct route to commercializing in Canada

Finding a commercialization partner is critical. Innovators must choose a partner with extensive connections, knowledge of local regulatory requirements and the international footprint necessary to realize economies of scale. Innomar Strategies draws on expertise from years of bringing complex therapies to market, meeting the demands of emerging therapies and the patients who need them.

CAR-TCR 

Access insights from the event.
Lung-I Cheng

Breakfast briefing with TrakCel

The evolving digitalization of supply chains

Lung-I Cheng
VP, Cell and Gene Therapy, Lung-I Cheng, was invited to join TrakCel’s breakfast briefing to discuss considerations for enabling treatment and commercial outcomes for advanced therapies and how orchestration processes will help make speed to therapy attainable.
Lung-I Cheng

Reuters Cell Therapy USA

Access insights from the event

Panel summary: Evaluate alternative revolutionary reimbursement models to craft a sustainable business model

Senior VP, Market Economics, David Senior, was joined by fellow industry experts from Bayer, Novartis Gene Therapies, and Point 32, to discuss new innovative payment strategies for cell and gene therapies.

Contact us

Our consultative approach and extensive reach across healthcare give us access to the best insights in the industry- insights we leverage to help commercialization challenges for our partners and patients they serve.